Avita Medical Inc Revenue Growth Rates (RCEL), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Avita Medical Inc   (NASDAQ: RCEL)
 

RCEL's Revenue Growth by Quarter and Year

Avita Medical Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

RCEL Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September -
2nd Quarter June 21.70
1st Quarter March 19.25
FY 40.95

RCELs Annual Revenue
Avita Medical Inc 's Revenue in the fiscal year 2025 $ 71.61 millions
Avita Medical Inc 's Revenue in the fiscal year 2024 $ 64.25 millions
Avita Medical Inc 's Revenue in the fiscal year 2023 $ 50.14 millions
Avita Medical Inc 's Revenue in the fiscal year 2022 $ 34.42 millions
Avita Medical Inc 's Revenue in the fiscal year 2021 $ 29.23 millions




RCEL Revenue second quarter 2026 Y/Y Growth Comment
Avita Medical Inc reported Revenue increase of 17.82% year on year in the second quarter 2026, to $ 21.70 millions, this is lower than Avita Medical Inc 's recent average Revenue rise of 89.49%.

Looking into second quarter 2026 results within Medical Equipment & Supplies industry 66 other companies have achieved higher Revenue growth. While Avita Medical Inc ' s Revenue growth of 17.82% ranks overall at the positon no. 1134 in the second quarter 2026.


RCEL Revenue ( Y/Y Growth %) 2026
 2025 2024 2023
4th Quarter December - -4.29 % 29.65 % 50.11 %
3rd Quarter September - -12.74 % 43.22 % 50.17 %
2nd Quarter June 17.82 % 21.18 % 29.36 % 40.89 %
1st Quarter March 4 % 66.76 % 5.21 % 39.92 %
FY   - 11.44 % 28.14 % -

Financial Statements
Avita Medical Inc 's second quarter 2026 Revenue $ 21.70 millions RCEL's Income Statement
Avita Medical Inc 's second quarter 2025 Revenue $ 18.42 millions Quarterly RCEL's Income Statement


RCEL Revenue (Quarter on Quarter Growth %)

 2026
 2025 2024 2023
4th Quarter December - 3.28 % -5.83 % 4.03 %
3rd Quarter September - -7.38 % 28.62 % 16.17 %
2nd Quarter June 12.74 % -0.49 % 36.94 % 11.37 %
1st Quarter March 9.25 % 0.54 % -21.83 % 11.52 %
FY (Year on Year)   - 11.44 % 28.14 % -


Back to RCEL Growth rate Comparisons >> Back to RCEL Growth rate Comparisons >>


Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #67
Healthcare Sector #217
Overall #1134

Revenue Y/Y Growth Statistics
High Average Low
1108.18 % 89.49 % -19.11 %
(Jun 30 2020)   (Mar 31 2026)
Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #67
Healthcare Sector #217
Overall #1134
Revenue Y/Y Growth Statistics
High Average Low
1108.18 % 89.49 % -19.11 %
(Jun 30 2020)   (Mar 31 2026)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Avita Medical Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
286.62 % 22.68 % -31.87 %
(Dec 31 2018)  


RCEL's II. Quarter Q/Q Revenue Comment
Avita Medical Inc achieved in the II. Quarter 2026 below company average Revenue rise of 12.74% quarter on quarter, to $ 21.70 millions.

Although the II. Quarter 2026 Revenue Q/Q growth was lower than the regular , this has been yet encouraging story, as the II. Quarter surge, eclipses the -0.49% growth in the II. Quarter a year ago

Within Medical Equipment & Supplies industry 31 other companies have achieved higher Revenue quarter on quarter growth. While Avita Medical Inc 's Revenue growth quarter on quarter, overall rank is 711.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #32
Healthcare Sector #119
Overall #711
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #32
Healthcare Sector #119
Overall #711
Revenue Q/Q Growth Statistics
High Average Low
286.62 % 22.68 % -31.87 %
(Dec 31 2018)  


RCEL's II. Quarter Q/Q Revenue Comment
Avita Medical Inc achieved in the II. Quarter 2026 below company average Revenue rise of 12.74% quarter on quarter, to $ 21.70 millions.

II. Quarter 2026 Revenue Q/Q growth were paradoxical, although lower than the regular, yet it demonstrates absolute recovery measured to the -0.49% in the II. Quarter a year ago.

Within Medical Equipment & Supplies industry 31 other companies have achieved higher Revenue quarter on quarter growth. While Avita Medical Inc 's Revenue growth quarter on quarter, overall rank is 711.


Avita Medical Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2026)		 12 Months Ending
(Mar 31 2026)		 12 Months Ending
(Dec 31 2025)		 12 Months Ending
(Sep 30 2025)		 12 Months Ending
(Jun 30 2025)
Cumulative Revenue 12 Months Ending $ 75.63 $ 72.35 $ 71.61 $ 72.40 $ 74.88
Y / Y Revenue Growth (TTM) 1 % 0.96 % 11.45 % 20.59 % 38.32 %
Year on Year Revenue Growth Overall Ranking # 430 # 309 # 227 # 269 # 180
Seqeuential Revenue Change (TTM) 4.54 % 1.03 % -1.09 % -3.32 % 4.5 %
Seq. Revenue Growth (TTM) Overall Ranking # 2102 # 1093 # 977 # 1065 # 1353


Cumulative Revenue growth Comment
Although Avita Medical Inc 's Annual Revenue growth year on year were below company's average 46.34% , Revenue announced in the Jun 30 2026 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 1% year on year, from 0.96% in Mar 31 2026.

In the Healthcare sector 107 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 309 to 430.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 115
Healthcare Sector # 108
Overall # 430

Revenue TTM Y/Y Growth Statistics
High Average Low
160.56 %
 46.34 %
0.96 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 115
Sector # 315
S&P 500 # 2102
Cumulative Revenue growth Comment
Although Avita Medical Inc 's Annual Revenue growth year on year were below company's average 46.34% , Revenue announced in the Jun 30 2026 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 1% year on year, from 0.96% in Mar 31 2026.

In the Healthcare sector 107 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 309 to 430.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 115
Healthcare Sector # 108
Overall # 430

Revenue TTM Y/Y Growth Statistics
High Average Low
160.56 %
46.34 %
0.96 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 115
Sector # 315
S&P 500 # 2102




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
RCEL's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue rise for the quarter ending Jun 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2026
Aclarion Inc 30.48%$ 30.483 millions
Harmony Biosciences Holdings inc 30.42%$ 30.421 millions
Personalis Inc 29.96%$ 29.960 millions
Beone Medicines Ltd 29.69%$ 29.693 millions
Capsovision Inc 29.60%$ 29.598 millions
Intuitive Surgical Inc 29.27%$ 29.272 millions
Xeris Biopharma Holdings Inc 28.74%$ 28.741 millions
Ultragenyx Pharmaceutical Inc 28.53%$ 28.532 millions
Innoviva Inc 28.39%$ 28.391 millions
Electrocore Inc 28.03%$ 28.031 millions
Lightwave Logic Inc 27.91%$ 27.909 millions
American Shared Hospital Services27.15%$ 27.149 millions
Protalix Biotherapeutics inc 27.07%$ 27.066 millions
Alkermes Plc 26.97%$ 26.968 millions
Lucid Diagnostics Inc 26.74%$ 26.741 millions
Lifestance Health Group Inc 26.08%$ 26.076 millions
Ani Pharmaceuticals Inc25.87%$ 25.866 millions
Sight Sciences Inc 25.83%$ 25.830 millions
Grail Inc 25.72%$ 25.723 millions
Fortress Biotech Inc 25.66%$ 25.658 millions
Apyx Medical Corp25.27%$ 25.273 millions
Radnet Inc 24.99%$ 24.986 millions
Precipio inc 24.18%$ 24.178 millions
Krystal Biotech Inc 24.14%$ 24.135 millions
Viemed Healthcare Inc 23.85%$ 23.853 millions
Ardelyx inc 23.77%$ 23.771 millions
Insulet Corporation23.51%$ 23.509 millions
Veracyte Inc 23.45%$ 23.448 millions
Journey Medical Corp23.33%$ 23.326 millions
Twist Bioscience Corporation23.24%$ 23.235 millions


About Avita Medical Inc Revenue Growth Rates (RCEL), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Avita Medical Inc (CIK 1762303).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001193125-26-338101
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Avita Medical Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.